Anna-Belle Beau
Anna-Belle Beau

Research assistant


Publication year:
  1. 2018
  2. Published

    Limitations in the Effect of Screening on Breast Cancer Mortality

    Beau, Anna-Belle, Andersen, Per Kragh, Vejborg, I. & Lynge, Elsebeth, 2018, In : Journal of Clinical Oncology. 36, 30, p. 2988-2995 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Overdiagnosis in breast cancer screening

    Lynge, Elsebeth, Napolitano, George, Vejborg, I. & Beau, Anna-Belle, 2018, In : Translational Cancer Research. 7, 5, p. 1313-1318 6 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  4. 2017
  5. Published

    Benefit-to-harm ratio of the Danish breast cancer screening programme

    Beau, Anna-Belle, Lynge, Elsebeth, Njor, S. H., Vejborg, I. & Lophaven, S. N., 1 Aug 2017, In : International Journal of Cancer. 141, 3, p. 512–518 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Impact of assumptions: the example of the Welch-analysis of mammography screening effectiveness

    Lynge, Elsebeth, Beau, Anna-Belle & Lophaven, S., Aug 2017, In : Acta Oncologica. 56, 8, p. 1131-1133 3 p.

    Research output: Contribution to journalComment/debateResearch

  7. Published

    Overdiagnosis in breast cancer screening: The impact of study design and calculations

    Lynge, Elsebeth, Beau, Anna-Belle, Christiansen, P., von Euler-Chelpin, My Catarina, Kroman, Niels Thorndahl, Njor, S. & Vejborg, I., Jul 2017, In : European Journal of Cancer. 80, p. 26-29 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics

    Hurault-Delarue, C., Chouquet, C., Savy, N., Lacroix, I., Beau, Anna-Belle, Montastruc, J. & Damase-Michel, C., May 2017, In : Pharmacoepidemiology and Drug Safety. 26, 5, p. 561-569 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study

    Graner, S., Svensson, T., Beau, Anna-Belle, Damase-Michel, C., Engeland, A., Furu, K., Hviid, A., Håberg, S. E., Mølgaard-Nielsen, D., Pasternak, B. & Kieler, H., 28 Feb 2017, In : The BMJ. 356, p. 1-8 8 p., j629.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. 2016
  11. Risk of infections during the first year of life after in utero exposure to drugs acting on immunity: A population-based cohort study

    Palosse-Cantaloube, L., Hurault-Delarue, C., Beau, Anna-Belle, Montastruc, J., Lacroix, I. & Damase-Michel, C., Nov 2016, In : Pharmacological Research. 113, Part A, p. 557-562 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Prescription of asthma medications before and during pregnancy in France: an observational drug study using the EFEMERIS database

    Beau, Anna-Belle, Didier, A., Hurault-Delarue, C., Montastruc, J., Lacroix, I. & Damase-Michel, C., 22 Sep 2016, In : Journal of Asthma. p. 0

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database

    Beau, Anna-Belle, Montastruc, J., Lacroix, I., Montastruc, F., Hurault-Delarue, C. & Damase-Michel, C., Aug 2016, In : British Journal of Clinical Pharmacology. 82, 2, p. 478-86 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 151917295